Whole-Brain Radiotherapy Combined With Anlotinib for Multiple Brain Metastases From Non-small Cell Lung Cancer Without Targetable Driver Mutation: A Single-Arm, Phase II Study

Authors
Category Primary study
JournalClinical Medicine Insights: Oncology
Year 2022
This article has no abstract
Epistemonikos ID: b5b8186d78f5eda5bf35a7cb9e5074228896a8a4
First added on: Feb 14, 2023